Versican

Perspectives on Developmental Neurobiology

Volumn 3, Issue 4, 1996, Pages 261-271

  Lebaron, Richard G ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Cell migration; Nerve pattering; Proteoglycan; Versican

Indexed keywords

CSPG2 PROTEIN, HUMAN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; LECTIN; PROTEOCHONDROITIN SULFATE; SCLEROPROTEIN; VERSICAN;

ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; TISSUE DISTRIBUTION;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; HUMANS; LECTINS, C-TYPE; PROTEOCHONDROITIN SULFATES; TISSUE DISTRIBUTION; VERSICANS;

EID: 0030340040     PISSN: 10640517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. Margolis, R.K., and Margolis. R.U. (1993). Nervous tissue proteoglycans. Experientia, 49, 429-4-46.
2. Lander, A.D. (1993). Proteoglycans in the nervous system. Curr Opin. Neurobiol. 3, 716-723.
3. Margolis, R.U., and Margolis. R.K. (1994). Aggrecan-versican-neurocan family of proteoglycans. In Met. Enzymo., Extracellular Matrix Components (E. Ruoslahti and E. Engvall, eds), pp. 105-126, Academic Press, San Diego.
4. Oohira, A., Katoh-Semba, R., Watanabe, E., and Matsui, F. (1994). Brain development and multiple molecular species of proteoglycan. Neurosci. Res. 20, 195-207.
5. Kiang, W-L., Margolis, R.U., and Margolis, R.K. (1981). Fractionation and properties of a chondroitin sulfate proteoglycan and the soluble glycoproteins of brain. J. Biol. Chem. 265, 10529-10537.
6. Herndon, M.E., and Lander, A.D. (1990). A diverse set of developmentally regulated proteoglycans is expressed in the rat central nervous system. Neuron 4, 949-961.
7. Lasky, L.A. (1992). Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 258, 964-969.
8. McEver, R.P. (1994). Selectins. Curr. Opin. Immunol. 6, 75-84.
9. Doege, K., Sasaki, M., Horigan, E., Hassell, J.R., and Yamada, Y. (1987). Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones. J. Biol. Chem. 262, 17757-17767.
10. Doege, K.J., Sasaki, M., Kimura, T., and Yamada, Y. (1991). Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. J. Biol. Chem. 266, 894-902.
11. Li, H., Schwartz N.B., and Vertel B., M. (1993). cDNA cloning of chick cartilage chondroitin sulfate (aggrecan) core protein and identification of a stop codon in the aggrecan gene associated with the chondrodystrophy, nanomelia. J. Biol. Chem. 268, 23504-23511.
12. Rauch, U., Karthikeyan, L., Maurel, P., Margolis, R.U., and Margolis, R.K. (1992). Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J. Biol. Chem. 267, 19536-19547.
13. Yamada, H., Watanabe, K., Shimonaka, M., and Yamaguchi, Y. (1994). Molecular cloning of brevican, a novel brain pro-teoglycan of the aggrecan/versican family. J. Biol. Chem. 269, 10119-10126.
14. Zimmermann, D.R., and Ruoslahti, E. (1989). Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 8, 2975-2981.
15. Fryer, H.J. L., Kelly, G.M., Molinaro, L., and Hockfield, S. (1992). The high molecular weight Cat-301 chondroitin sulfate proteoglycan from brain is related to the large aggregating proteoglycan from cartilage, aggrecan. J. Biol. Chem. 267, 9874-9883.
16. Iwata, M., and Carlson, S.S. (1993). A large chondroitin sulfate proteoglycan has the characteristics of a general extracellular matrix component of adult brain. J. Neurosci. 13, 195-207.
17. Goldstein, L.A., Zhou, D.F.H., Picker, L.J., Minty, C.N., Bargatze, R.F., Ding, J.F., and Butcher, E.C. (1989). A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56, 1063-1072.
18. Stamenkovic, I., Amiot, M., Pesando, J.M., and Seed, B. (1989). A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56, 1057-1062.
19. DeÓk, F., Kiss, L, Sparks, K.J., Argraves, W.S., Hampikian, G., and Goetinck, P.F. (1986). Complete amino acid sequence of chicken cartilage link protein deduced from cDNA clones. Proc. Natl. Acad. Sci. USA 83, 3766-3770.
20. Doege, K., Hassell, J.R., Caterson, B., and Yamada, Y. (1986). Link protein cDNA sequence reveals a tandemly repeated protein structure. Proc. Natl. Acad. Sci. USA 83, 3761-3765.
21. Kiss, I., DeÓk, F., Mestríc, S., Delius, H., Soos, J., DékÓny, K., Argraves, W.S., Sparks, K.J., and Goetinck, P.F. (1987). Structure of the chicken link protein gene: exons correlate with the protein domains. Proc. Natl. Acad. Sci. USA 84, 6399-6403.
22. Krusius, T., Gehlsen, K.R., and Ruoslahti, E. (1987). A fibroblast chondroitin sulfate proteoglycan core protein contains lectin-like and growth factor-like sequences. J. Biol. Chem. 262, 13120-13125.
23. Kimata, K., Oike, Y., Tani, K., Shinomura, T., Yamagata, M., Uritani, M., and Suzuki, S. (1986). A large chondroitin sulfate proteoglycan (PG-M) synthesized before chondrogenesis in the limb bud of chick embryo. J. Biol. Chem. 261, 13517-13525.
24. Shinomura, T., Jensen, K.L., Yamagata, M., Kimata, K., and Sloursh, M. (1990). The distribution of mesenchyme proteoglycan (PG-M) during wing bud outgrowth. Anal. Embryol. (Berl. 181, 227-233.
25. Shinomura, T., Nishida, Y, Ito, K., and Kimata, K. (1993). cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. J. Biol. Chem. 268, 14461-14469.
26. Ito, K., Shinomura, T., Zako, M., Ujita, M., and Kimata, K. (1995). Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J. Biol. Chem. 270, 958-965.
27. Iozzo, R.V., Naso, M.F., Cannizzaro, L.A., Wasmuth, J.J., and McPherson, J.D. (1992). Mapping of the versican proteoglycan gene (CSPG2) to the long arm of human chromosome 5 (5q12-5q14). Genomics 14, 845-851.
28. Naso, M.F., Morgan, J.L., Buchberg, A.M., Siracusa, L.D., and Iozzo, R.V. (1995). Expression pattern and mapping of the murine versican gene (Cspg2) to chromosome 13. Genomics 29, 297-300.
29. Naso, M.F., Zimmermann, D.R., and Iozzo, R.V. (1994). Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J. Biol. Chem. 269, 32999-33008.
30. Dours-Zimmermann, M.T., and Zimmermann, D.R. (1994). A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269, 32992-32998.
31. Zako, M., Shinomura, T., Ujita, M., Ito, K., and Kimata, K. (1995). Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment region in mouse and human tissues. J. Biol. Chem. 270, 3914-3918.
32. Braunewell, K-H., Martini, R., LeBaron, R., Kresse, H., Faissner. A., Schmitz, B., and Schachner, M. (1995). Up-regulation of a chondroitin sulfate epitope during regeneration of mouse sciatic nerve: evidence that the immunoreactive molecules are related to the chondroitin sulfate proteoglycans decorin and versican. Eur. J. Neurosci. 7, 792-804.
33. Yamagata, M., Shinomura, T., and Kimata, K. (1993). Tissue variation of two large chondroitin sulfate proteoglycans (PGM/versican and PG-H/aggrecan) in chick embryos. Anat. Embryol 187, 433-444.
34. Crawford, T.J., Melhado, I.G., and Jirik, F.R. (1993). Expression of versican mRNA is developmentally regulated in the brain of the embryonic chick and the developing rat. Dev. Brain Res. 76, 264-267.
35. Bignami, A., Perides, G., and Rahemtulla, F. (1993). Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain. J. Neurosci. Res. 34, 97-106.
36. Landolt, R.M., Vaughan, L., Winterhalter, K.H., and Zimmermann, D.R. (1995). Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 121, 2303-2312.
37. du Gros, D.L., LeBaron, R.G., and Couchman, J.R. (1995). Association of versican with dermal matrices and its potential role in hair follicle development and cycling. J. Invest. Dermato 105, 426-431.
38. Schonherr, E., Jarvelainen, H.T., Sandell, L.J., and Wight, T.N. (1991). Effects of platelet-derived growth factor and transforming growth factorASI on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem. 266, 17640-17647.
39. Lemire, J.M., Potter-Perigo, S., Hall, K.L., Wight, T.N., and Schwartz, S.M. (1996). Phenotypically distinct rat aortic smooth muscle cells differ in versican (PG-M) expression. Aterioscler. Thromb. Vas. Biol. 16, 821-829.
40. Zimmermann, D.R., Dours-Zimmermann, M.T., Schubert, M., and Bruckner-Tuderman, L. (1994). Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J. Cell Biol. 124, 817-825.
41. Bernstein, E.F., Fisher, L.W., Li, K., LeBaron, R.G., Tan, E.M.L., and Uitto, J. (1995). Differential expression of the versican and decorin genes in photoaged and sun-protected skin. Lab. Invest. 72, 662-669.
42. Shinomura, T., Zako, M., Ito, K., Ujita, M., and Kimata, K. (1995). The gene structure and organization of mouse PG-M, a large chondroitin sulfate proteoglycan. Genomic background for the generation of multiple PG-M transcripts. J. Biol. Chem. 270, 10328-10333.
43. Riccio, A., Pedone, P.V., Lund, L.R., Diesen, T., Olsen, H.S., and Andreasen, P.A. (1992). TGF-β1 -responsive element: closely associated binding sites for USF and CCAAT binding transcription factor-nuclear factor 1 in type 1 plasminogen activator inhibitor gene. Mol. Cell. Biol. 12, 1846-1855.
44. Mitchell, P.J., Timmons, P.M., Hébert, J.M., Rigby, P.W.J., and Tijan, R. (1991). Transcription factor AP-2 is expressed in neural crest cell linages during mouse embryogenesis. Genes Dev. 5, 105-119.
45. Krueger, R.C., Jr, Hennig, A.K., and Schwartz, N.B. (1992). Two immunologically and developmentally distinct chondroitin sulfate proteoglycans in embryonic chick brain. J. Biol. Chem. 267, 12149-12161.
46. Qwarnstrom, E.E., Jarvelainen, H.T., Kinsella, M.G., Ostberg, CO., Sandell, L.J., Page, R.C., and Wight, T.N. (1993). Interleukin-1 p regulation of fibroblast proteoglycan synthesis involves a decrease in versican steady-state mRNA levels. Biochem. J. 294, 613-620.
47. Kahari, V-M., Larjava, H., and Uitto, J. (1991). Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-\S1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol. Chem. 266, 10608-10615.
48. Rapraeger, A. (1989). Transforming growth factor (type β) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. J. Cell Biol. 109, 2509-2518.
49. Braunwell, K-H., Pesheva, P., McCarthy, J.B., Furcht, L.T., Schmitz, B., and Schachner, M. (1995). Functional involvement of sciatic nerve-derived versican- and decorin-like molecules and other chondroitin sulfate proteoglycans in ECM-mediated cell adhesion and neurite outgrowth. Eur. J. Neurosci. 7, 805-814.
50. Caterson, B., Griffin, J., Mahmoodian, F., and Sorrell, J.M. (1990). Monoclonal antibodies against chondroitin sulfate isomers: their use as probes for investigating proteoglycan metabolism. Biochem. Soc. Trans. 18, 820-823.
51. McQuillan, D.J., Yanagishita, M., Hascall, V.C., and Bickel, M. (1989). Proteoglycan biosynthesis in murine monocytic leukemic (M1) cells before and after differentiation. J. Biol. Chem. 264, 13245-13251.
52. Edwards, I.J., and Wagner, W.D. (1988). Distinct synthetic and structural characteristics of proteoglycans produced by cultured artery smooth muscle cells of atherosclerosis-susceptible pigeons. J. Biol. Chem. 263, 9612-9620.
53. Thyberg, J., and Fredholm, B.B. (1987). Induction of ornithine decarboxylase activity and putrescine synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factor. Exp. Cell Res. 170, 160-169.
54. Boyd, C.D., Pierce, R.A., Schwarzbauer, J.E., Doege, K., and Sandell, L.J. (1993). Alternate exon usage is a commonly used mechanism for increasing coding diversity within genes coding for extracellular matrix proteins. Matrix 13, 457-469.
55. Perides, G., Lane, W.S., Andrews, D., Dahl, D., and Bignami, A. (1989). Isolation and partial characterization of a glial hyaluronate-binding protein. J. Biol. Chem. 264, 5981-5987.
56. Perides, G., Asher, R.A., Lark, M.W., Lane, W.S., Robinson, R.A., and Bignami, A. (1995). Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican? Biocliem. J. 312, 377-384.
57. Sandy, J.D., Neame, P.J., Boynton, R.E., and Flannery, C.R. (1991). Catabolism of aggrecan in cartilage expiants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266, 8683-8685.
58. Lohmander, L.S., Neame, P.J., and Sandy, J.D. (1993). The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 36, 1214-1222.
59. Goetinck, P.F., Stripe, N.S., Tsonis, P.A., and Carlone, D. (1987). The tandemly repeated sequences of cartilage link protein contain the sites for interaction with hyaluronic acid. J. Cell Biol. 105, 2403-2408.
60. LeBaron, R.G., Zimmermann, D.R., and Ruoslahti, E. (1992) Hyaluronate binding properties of versican. J. Biol. Chem. 267, 10003-10010.
61. Perides, G., Rahemtulla, F., Lane, W.S., Asher, R.A. and Bignami, A. (1992). Isolation of a large aggregating proteoglycan from human brain. J. Biol. Chem. 267, 23883-23887.
62. Mörgelin, M., Paulsson, M., Hardingham, T.E., Heinegård, D., and Engel, J. (1988). Cartilage proteoglycans. Assembly with hyaluronate and link protein as studied by electron microscopy. Biochem. J. 253, 175-185.
63. Fosang, A.J., and Hardingham, T.E. (1989). Isolation of the N-terminal globular protein domains from cartilage proteoglycans. Biochem. J. 261, 801-809.
64. Grumet, M., Milev, P., Sakurai, T., Karthikeyan, L., Bourdon, M., Margolis, R.K., and Margolis, R.U. (1994). Interactions with tenascin and differential effects in cell adhesion of neurocan and phosphacan, two major chondroitin sulfate proteoglycans of nervous tissue. J. Biol. Chem. 269, 12142-12146.
65. Salmivirta, M., Elenius, K., Vainio, S., Hofer, U., Chiquet-Ehrismann, R., Thesleff, I., and Jalkanen, M. (1991). Syndecan from embryonic tooth mesenchyme binds tenascin. J. Biol. Chem. 266, 7733-7739.
66. Barnea, G., Grumet, M., Milev, P., Silvennoinen, O., Levy, J.B., Sap, J., and Schlessinger, J. (1994). Receptor tyrosine phosphatase β is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. J. Biol. Chem. 269, 14349-14352.
67. Aspberg, A., Binkert, C., Ruoslahti, E. (1995). The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc. Natl. Acad. Sci. USA 92, 10590-10594.
68. Ujita, M., Shinomura, T., Ito, K., Kitagawa, Y., and Kimata, K. (1994). Expression and binding activity of the carboxy-terminal portion of the core protein of PG-M, a large chondroitin sulfate proteoglycan. J. Biol. Chem. 269, 27603-27609.
69. Woods, A., Couchman, J.R., Johansson, S., and Höök, M. (1986). Adhesion and cytoskeletal organization of fibroblasts in response to fibronectin fragments. EMBO J. 5, 665-670.
70. LeBaron, R.G., Esko, J.D., Woods, A., Johansson, S., and Höök, M. (1988). Adhesion of glycosaminoglycan-deficient Chinese hamster ovary cell mutants to fibronectin substrata. J. Cell Biol. 106, 945-952.
71. Woods, A., McCarthy, J.B., Furcht, L.T., and Couchman, J.R. (1993). A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol. Biol. Cell 4, 605-613.
72. Yamagata, M., Yamada, K.M., Yoneda, M., Suzuki, S., and Kimata, K. (1986). Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. J. Biol. Chem. 261, 13526-13535.
73. Muller-Eberhard, H.J. (1988). Molecular organization and function of the complement system. Annu. Rev. Biochem. 57, 321-347.
74. Bode-Lesniewska, B., Dours-Zimmermann, M.T., Odermatt, B.F., Briner, J., Heitz, P.U., and Zimmermann, D.R. (1996). Distribution of the large aggregating proteoglycan versican in adult human tissues. J. Histochem. Cytochem. 44, 303-312.
75. LeBaron, R.G., Hagg, T., Varon, S., Louis, J.C., and Ruoslahti, E. (1996). Versican is a constituent of adult brain extracellular matrix expressed by oligodendrocytes. (In preparation).
76. Apostolski, S., Sadiq, S.A., Hays, A., Corbo, M., Suturkova-Milosevic, L., Chaliff, P., Stefansson, K., LeBaron, R.G., Ru-oslahti, E., Hays, A.P., and Latov, N. (1994). Identification of GaI(\SI-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J. Neurosci. 38, 134-141.
77. Perides, G., Erickson, H.P., Rahemtulla, F., and Bignami, A. (1993). Colocalization of tenascin with versican, a hyaluronate-binding chondroitin sulfate proteoglycan. Anat. Embryol. 188, 467-179.
78. Toole, B.P. (1990). Hyaluronan and its binding properties, the hyaladherins. Curr. Opin. Cell Biol. 2, 839-44.
79. Eggli, P.S., Lucocq, J., Ott, P., Graber, W., and Van Der Zypen, E. (1992). Ultrastructural localization of hyaluronan in myelin sheaths of the rat central and rat and human peripheral nervous systems using hyaluronan-binding protein-gold and link protein-gold. Neuroscience 48, 737-744.
80. Huskisson, E.C. (1990). Clinical aspects of chondroprotection. Semin. Arthritis Rheum. 19 (suppl. 1), 30-32.
81. Ghosh, P., Wells, C., Smith, M., and Hutadilok, N. (1990). Chondroprotection, myth or reality: an experimental approach. Semin. Arthritis Rheum. 19 (suppl. 1), 3-9.
82. Mevorach, D., and Menkes, C.J. (1994). Osteoarthritis and chondroprotection. Isr. J. Med. Sci. 30, 928-931.
83. Rathjen, F.G., Wolff, J.M., and Chiquet-Ehrismann, R. (1991). Restrictin: A chick neural extracellular matrix protein involved in cell attachment co-purifies with the cell recognition molecule F11. Develop 113, 151-164.
84. Chiquet-Ehrismann, R. (1991). Anti-adhesive molecules of the extracellular matrix. Curr. Opin. Cell Biol. 3, 800-804.
85. Sage, E.H., and Bornstein, P. (1991). Extracellular proteins that modulate cell-matrix interactions. J. Biol. Chem. 266, 14831-14834.
86. Pesheva, P., Probstmeier, R., Skubitz, A.P., McCarthy, J.B., Furcht, L.T., and Schachner, M. (1994). Tenascin-R (J1 160/180) inhibits fibronectin-mediated cell adhesion-functional relatedness to tenascin-C. J. Cell Sci. 107, 2323-2333.
87. Yamagata, M., and Kimata, K. (1994). Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican. J. Cell Sci. 107, 2581-2590.
88. Yamagata, M., Saga, S., Kato, M., Bernfield, M., and Kimata, K. (1993). Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. J. Cell Sci. 106, 55-65.
89. Brennan, M.J., Oldberg, Å., Hayman, E.G., and Ruoslahti, E. (1983). Effect of a proteoglycan produced by rat tumor cells on their adhesion to fibronectin-collagen substrata. Cancer Res. 43, 4302-4307.
90. Lewandowska, K., Choi, H.U., Rosenberg, L.C., Zardi, L., and Culp, L.A. (1987). Fibronectin-mediated adhesion of fibroblasts: Inhibition by dermatan sulfate proteoglycan and evidence for a cryptic glycosaminoglycan-binding domain. J. Cell Biol. 105, 1443-1454.
91. Yamagata, M., Suzuki, S., Akiyama, S.K., Yamada, K.M., and Kimata, K. (1989). Regulation of cell substrate adhesion by proteoglycans immobilized on extracellular substrates. J. Biol. Chem. 264-8012-8018.
92. Bidanset, D.J., LeBaron, R., Rosenberg, L., Murphy-Ullrich, J.E., and Höök, M. (1992). Regulation of cell substrate adhesion: Effects of small galactosaminoglycan-containing proteoglycans. J. Cell Biol. 118, 1523-1531.
93. Funderburg, F.M., and Markwald, R.R. (1986). Conditioning of native substrates by chondroitin sulfate proteoglycans during cardiac mesenchymal cell migration. J. Cell Biol. 103, 2475-2487.
94. Grumet, M., Friedlander, D.R., and Sakurai, T. (1996). Functions of brain chondroitin sulfate proteoglycans during development; interactions with adhesion molecules. Perspectives on Developmental Neurobiology. Grumet et. al. 1, 319-330
95. Snow, D.M., Steindler, D.A., and Silver, J. (1990). Molecular and cellular characterization of the glial roof plate of the spinal cord and optic tectum: A possible role for a proteoglycan in the development of an axon barrier. Dev. Biol. 138, 359-376.
96. Bicknese, A.R., Sheppard, A.M., O'Leary, D.D.M., and Pearlman, A.L. (1994). Thalamocortical axons extend along a chondroitin sulfate proteoglycan-enriched pathway coincident with the neocortical subplate and distinct from the efferent path. J. Neurosci. 14, 3500-3510.
97. Kjellen, L., and Lindhal, U. (1991). Proteoglycans: Structures and interactions. Annu. Rev. Biochem. 60, 443-475.
98. Brown, C.T., Vural, M., Johnson, M., and Trinkaus-Randall, V. (1994). Age-related changes of scierai hydration and sulfated glycosaminoglycans. Mech. Ageing Dev. 77, 97-102.